Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

How Much Does CAR-T Cost in Vietnam?

The cost of CAR-T (Chimeric Antigen Receptor T-Cell) Therapy in Vietnam typically ranges between USD 30000 - USD 50000. However, this cost can vary widely depending on several factors, including the type of cancer being treated, the specific CAR-T product used, the hospital's facilities, the oncologist’s experience, and the patient’s overall condition.

Additionally, expenses related to cell collection, laboratory processing, hospital stay, intensive monitoring, medications, and post-treatment follow-up can significantly influence the total cost.

Factors Influencing the Cost of CAR-T

Type of CAR-T Treatment: Different CAR-T products are used for conditions such as lymphoma, leukemia, or multiple myeloma. The type of malignancy and CAR-T formulation greatly impact overall expenses, as some therapies require more complex cell engineering or multiple treatment stages.
Hospital and Location: Hospitals in major Vietnamese cities like Hanoi and Ho Chi Minh City generally charge higher due to advanced oncology centres, immunotherapy labs, and specialised nursing care. International hospitals tend to be costlier than government facilities.
Oncologist & Immunotherapy Specialist Expertise: CAR-T requires a specialised team trained in cellular and immunotherapy treatments. Highly experienced oncologists or haematologists with international training may charge higher fees due to advanced skill sets.
Diagnostic & Pre-Treatment Tests: Before CAR-T therapy, patients undergo extensive screening such as PET/CT, bone marrow biopsy, immunophenotyping, viral screening, blood tests, and cardiac evaluations to ensure suitability. These tests add to the overall cost.
Cell Collection & Laboratory Engineering: CAR-T involves collecting the patient’s T-cells and modifying them in advanced laboratories. This lab process is one of the most cost-intensive components, contributing significantly to treatment pricing.
Hospitalisation & Post-Treatment Care: Patients usually require strict monitoring for several days to weeks due to risks of cytokine release syndrome (CRS) and neurotoxicity. ICU care, supportive medications, and follow-up visits add to the final cost.
Length of Hospital Stay: The duration of stay depends on patient response, recovery, and management of side effects. Longer hospitalisation leads to higher overall treatment expenses.

What's included in your CAR-T quote?

CAR-T product & infusion

Drug, leukapheresis, conditioning chemo

Oncology team consults

Pre, intra, post-infusion

2-day hospital + ICU as needed

CRS & neurotoxicity management

30-day in-country monitoring

Imaging, labs, follow-ups

Visa & medical-visa invite letter

Airport pickup & transfers

Get Itemized Quote FREE

Cost of CAR-T in Major Cities of Vietnam

City	Cost (USD)
Can Tho	$30,000 – $50,000	Explore More
Da Nang	$30,000 – $50,000	Explore More
Ha noi	$24,000 – $40,000	Explore More
Ho Chi Minh	$30,000 – $50,000	Explore More
Nha Trang	$27,000 – $45,000	Explore More
Phu Quoc	$27,000 – $45,000	Explore More

Car T - Vietnam Vs the World

$25k - $55k

$30k - $56k

$30k - $50k

$45k - $65k

$75k - $125k

$150k - $470k

$200k - $300k

$320k - $450k

$373k - $500k

$373k - $475k

$475k - $0

Author

Alvina Hasan

M.Pharm

2 Year of Experience

Last Reviewed - June 2026

Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.

With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.

Readers can explore her published research and articles here:

https://carcinogenesis.com/index.php/JOC/article/view/868

https://carcinogenesis.com/index.php/JOC/article/view/870

Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.

CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.

This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.

Classification:

CAR T cell therapy is classified as follows:

Structure-based classification:
First-generation CAR T-cells: These CAR T-cells typically consist of an antigen-binding domain (single-chain variable fragment, scFv) linked to a T-cell activation domain, such as the CD3ζ chain. They lack additional co-stimulatory domains.
Second-generation CAR T-cells: These CAR T-cells include an additional co-stimulatory domain, such as CD28 or 4-1BB (CD137), along with the CD3ζ chain. The presence of co-stimulatory domains enhances T-cell activation and persistence.
Third-generation CAR T-cells: These CAR T-cells incorporate two co-stimulatory domains along with the CD3ζ chain, aiming to further enhance T-cell function and anti-tumor activity.

Antigen-based classification: It includes

CD19-targeted CAR T-cells: CD19 is a common target for CAR T-cell therapy and is used in the treatment of B-cell malignancies such as acute lymphoblastic leukemia (ALL) and certain types of lymphoma.
Other antigen-targeted CAR T-cells: CAR T-cells can be engineered to target a variety of antigens expressed on cancer cells, including but not limited to BCMA (B-cell maturation antigen), CD22, CD30, and EGFRvIII.

Frequently Asked Questions

CAR-T therapy is used to treat certain blood cancers, including:

Diffuse Large B-Cell Lymphoma (DLBCL)

Acute Lymphoblastic Leukemia (ALL)

Follicular Lymphoma

Mantle Cell Lymphoma

Multiple Myeloma

CAR-T treatment involves several stages:

Yes. CAR-T therapy can cause side effects such as cytokine release syndrome (CRS), fever, fatigue, low blood pressure, neurological changes, infection, and low blood counts. These side effects may require specialised supportive care. However, with proper monitoring, most patients recover well.

Some well-known hospitals offering advanced cancer and cellular therapies in Vietnam include:

Vinmec Hai Phong

Vinmec Ha Long Hospital

Vinmec Central Park International Hospital

Vinmec Times City

Vinmec Smart City Hospital

Recovery varies based on the patient's response and cancer type. Most patients stay in the hospital for 2–4 weeks, followed by regular follow-ups for several months to monitor immune recovery and therapy effectiveness.

Additional expenses include diagnostic tests, hospitalisation charges, ICU care (if needed), medications, supportive therapy, follow-up consultations, and management of side effects. International patients may also need to budget for travel, accommodation, and interpreter services.

The best cities for CAR-T therapy are:

Hanoi – for its major cancer institutes and research centres

Ho Chi Minh City – for advanced private and government oncology hospitals

Vietnam offers advanced cancer care with modern immunotherapy facilities, internationally trained oncology teams, and competitive pricing compared to many other countries. The country is also known for shorter waiting times and high-quality patient support services.

The success rate is generally promising, especially for patients with relapsed or refractory blood cancers. Many patients achieve remission or long-term disease control, especially when treated in specialised oncology centres with strong immunotherapy expertise.

Welcome To MediGence

Your Notifications

CAR-T Cost in Vietnam

Get Your Personalised Treatment Plan in Just 24 Hours.

How Much Does CAR-T Cost in Vietnam?

Factors Influencing the Cost of CAR-T

What's included in your CAR-T quote?

Cost of CAR-T in Major Cities of Vietnam